A Case Series: Methylene-Blue-Related Toxic Anterior Segment Syndrome (2025)

Peer-Reviewed Study · Alabbasi O, Alahmadi MW, Alsaedi MG, AlShammari AZAM · May 20, 2025

Alabbasi O et al., 2025-05-20: Case series of three patients inadvertently given 1% methylene blue into the anterior chamber during cataract surgery, two of whom developed irreversible corneal endothelial decompensation requiring endothelial keratoplasty.

An intracameral injection of methylene blue 1% during cataract surgery induces extreme cytotoxicity, primarily affecting the corneal endothelium and iris epithelium.

Alabbasi O et al., 2025-05-20: Case series of three patients inadvertently given 1% methylene blue into the anterior chamber during cataract surgery, two of whom developed irreversible corneal endothelial decompensation requiring endothelial keratoplasty. C8 (product concentration/grade used off-label causing injury) and C5 (site toxicity). Dose/route: intracameral 1% methylene blue (a concentration prepared for other purposes), single exposure; no light dose. Funder/conflicts not stated in abstract. Comparator: none. The 1% figure matters for C8: it is a concentrated dye solution, not the 5 mg/mL (0.5%) injection, and the harm is described as concentration-driven cytotoxicity.